KRTX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own KRTX shares is 429, representing 86.32% of the company's common stock.

STATE OF WISCONSIN INVESTMENT BOARD, in the last quarter, reduced its stake in KRTX by -100% restricting it's holding to 0 shares of worth nearly -. DIMENSIONAL FUND ADVISORS LP also lessened -100% of the KRTX shares from its portfolio, reducing its holding to 0 shares of worth -. MML INVESTORS SERVICES, LLC also shunned KRTX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, VANGUARD GROUP INC increased its stake in KRTX by 0.66% in the last quarter. The institutional holder raised its holding to 3.22 million shares having worth more than $1.02B. BLACKROCK INC. also added 2.67% more shares of KRTX to its portfolio, raising its holding to 2.02 million shares of worth $637.89M. STATE STREET CORP also increased its KRTX shares holding by 4.92% which brought its holding to 974.64 thousand shares worth $308.48M.

The insider with the most stakes in KRTX is Brannan Stephen K. , Chief Medical Officer at the company. Additionally, KRTX stock is highly held by Chief Financial Officer Ignelzi Troy A. and Chief Operating Officer Miller Andrew Craig among others.

Company executives, directors, and other insiders own 4.99% percent of Karuna Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which KRTX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include BRANNAN STEPHEN K., JONAS JEFFREY M, and IGNELZI TROY A..

There have been 0 transaction(s) during the past 6-months in which Karuna Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 Karuna Therapeutics, Inc. shares are held by insiders, which represents about 4.99% of KRTX stock.

KRTX Chief Medical Officer, Brannan Stephen K. holds the largest portfolio of the company's shares. KRTX shares owned by Brannan total nearly 42.6 thousand.

STATE OF WISCONSIN INVESTMENT BOARD is the largest institutional owner in KRTX which holds 0 shares worth - or 0% of the total KRTX shares outstanding followed by DIMENSIONAL FUND ADVISORS LP with ownership of 0 shares representing 0% of the KRTX ownership. MML INVESTORS SERVICES, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the KRTX is concerned, it is a stock which is not optionable.

Number of KRTX shares short is 1.97M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 38.20M shares of KRTX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, KRTX has 36.27M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for KRTX is 3.6.